Bombardier to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 GlobeNewswire February 02, 2026 MONTRÉAL, Feb. 02, 2026 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) will publish its financial results for the fourth quarter full year 2025 on February 12, 2026. Financial results for the fourth quarter and full year 2025 […]

EYLEA HD(R) (aflibercept) Injection 8 mg Presentations at Angiogenesis 2026 Underscore Strength of its Clinical Profile for the Treatment of Serious Retinal Diseases New presentations include final 64-week results from the Phase 3 QUASAR trial in patients with retinal vein occlusion, as well as full primary results from the Phase 3b ELARA trial in patients

WeChange Launches Across 190+ Countries to Expand Crypto Access Worldwide Platform launched January 30, enabling low-fee crypto access through local bank transfers GlobeNewswire February 02, 2026 Budapest, Hungary, Feb. 02, 2026 (GLOBE NEWSWIRE) — WeChange, a noncustodial global crypto onramp, announces the official launch of its noncustodial fiat-to-crypto on-ramp, designed to simplify how everyday users

Woodward Increases Quarterly Dividend by 14 Percent GlobeNewswire February 02, 2026 FORT COLLINS, Colo., Feb. 02, 2026 (GLOBE NEWSWIRE) — Woodward, Inc. (NASDAQ:WWD) today announced that its Board of Directors declared a cash dividend of $0.32 per share, an increase of 14 percent from the prior quarter's dividend of $0.28 per share. The dividend will

Canadian Premium Sand Inc. Announces the Resignation of a Director GlobeNewswire February 02, 2026 CALGARY, Alberta, Feb. 02, 2026 (GLOBE NEWSWIRE) — Canadian Premium Sand Inc. (“CPS” or the “Company“) (TSXV: CPS) announces that Rodrigo Sousa has resigned from the Company's Board of Directors effective January 29th. Mr. Sousa has been a director of the

Guidelight Expands to California with Opening of Los Angeles Clinic Leading Provider of Evidence-Based Mental Health Treatment Brings Services to West LA GlobeNewswire February 02, 2026 LOS ANGELES, Feb. 02, 2026 (GLOBE NEWSWIRE) — Guidelight, a leader in evidence-based mental health care, is proud to announce the opening of its newest location in the vibrant

Iridex Announces Plans to Relocate Headquarters Move expected to generate significant cost savings GlobeNewswire February 02, 2026 MOUNTAIN VIEW, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) — Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced

illumin announces board of directors' transition GlobeNewswire February 02, 2026 TORONTO, Feb. 02, 2026 (GLOBE NEWSWIRE) — illumin Holdings Inc. (TSX:ILLM) (OTCQB:ILLMF) (“illumin” or the “Company“) today announced changes to its board of directors (the “Board“) and the composition of its audit committee (“Audit Committee“) and corporate compensation and governance committee (“CCGC“). The Board has

Agomab Announces Launch of Initial Public Offering GlobeNewswire February 02, 2026 ANTWERP, Belgium, February 2, 2026 (GLOBE NEWSWIRE) – AgomAb Therapeutics NV (“Agomab”), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need, today announced the launch

Groundbreaking therapy for advanced heart failure Repairon expands to North America to Accelerate Clinical Trials and Product Development GlobeNewswire February 02, 2026 GÖTTINGEN, Germany, Feb. 02, 2026 (GLOBE NEWSWIRE) — German biotech company Repairon GmbH announced the formation of its fully owned subsidiary, Repairon USA, Inc., to enable the expansion of clinical trials and pursue